title: Use of clinical and laboratory features to define prognostic subgroups in B-precursor acute lymphoblastic leukemia: experience of the Pediatric Oncology Group.
authors.affiliation: Duke University Medical Center, Durham, NC 27710.
authors.forename: M J
authors.initials: MJ
authors.lastname: Borowitz
authors.forename: A J
authors.initials: AJ
authors.lastname: Carroll
authors.forename: J J
authors.initials: JJ
authors.lastname: Shuster
authors.forename: A T
authors.initials: AT
authors.lastname: Look
authors.forename: F G
authors.initials: FG
authors.lastname: Behm
authors.forename: D J
authors.initials: DJ
authors.lastname: Pullen
authors.forename: V J
authors.initials: VJ
authors.lastname: Land
authors.forename: P
authors.initials: P
authors.lastname: Steuber
authors.forename: W M
authors.initials: WM
authors.lastname: Crist
mesh_terms: D015703:Antigens, CD / Q000032:analysis; D002648:Child; D006801:Humans; D016130:Immunophenotyping; D011003:Ploidies; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics / Q000276:immunology / Q000401:mortality*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics / Q000276:immunology / Q000401:mortality*; D011379:Prognosis; D015996:Survival Rate
chemical_list: D015703:Antigens, CD